Candesartan CAS 139481-59-7 Kuchena > 99.0% (HPLC) Factory
Ruifu Chemical Supply Candesartan Cilexetil Yepakati Nekuchena Kwakanyanya
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Yepakati Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Yepakati CAS 139481-44-0
Trityl Candesartan Cilexetil CAS 170791-09-0
Chemical Name | Candesartan |
Mashoko anoreva zvakafanana | CV-11974;2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl) [1,1'-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-Carboxylic Acid;3- [[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl]methyl]-2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G |
Nhamba yeCAS | 139481-59-7 |
Nhamba yeCAT | RF-PI1889 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C24H20N6O3 |
Molecular Weight | 440.45 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | White Powder |
Kuzivikanwa-HPLC | Nguva Yekuchengeta Yakafanana neStandard |
Kuzivikanwa-IR | Zvakafanana neStandard |
Kuchena / Analysis Method | >99.0% (HPLC) |
Melting Point | 183.0~185.0℃ |
Kurasika paKuomesa | <0.50% |
Kunyorova (KF) | <0.50% |
Residue paIgnition | <0.50% |
Heavy Metals | <20ppm |
Kusachena Kwemunhu | <1.00% (HPLC) |
Zvose Zvisina Kuchena | <1.00% (HPLC) |
Refractive Index | n20/D 1.745~1.747 |
Test Standard | Enterprise Standard |
Usage | API;Zvekurapwa kweHypertension |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Candesartan (CAS: 139481-59-7) is angiotensin II receptor antagonist ine IC50 ye0.26 nM.Chinangwa: Angiotensin II Receptor candesartan inoratidzwa pakurapa hypertension.Candesartan Cilexetil yakatanga kubvumidzwa muGB muna Kubvumbi 29, 1997, ndokuzotenderwa neUS Food and Drug Administration (FDA) musi waChikumi 4, 1998, uye yakabvumidzwa nePharmaceuticals and Medical Devices Agency yeJapan (PMDA) musi waKurume 12, 1999. Yakagadzirwa neAstraZeneca, ikazotengeswa seAtacand neAstraZeneca muGB neUS, uye yakatengeswa seBlopress naTakeda muJP.Candesartan Cilexetil inonzi angiotensin II receptor blocker (ARB), inovhara vasoconstrictor uye aldosterone-secreting mhedzisiro yeangiotensin II nekusarudza kuvharira kusungwa kweangiotensin II kune AT1 receptor mumatishu akawanda, akadai sevascular smooth muscle uye adrenal gland.Atacand inoratidzirwa kurapwa kwehutano hwepamusoro muvakuru nevana 1 kusvika